Prevention of cancers of the breast, endometrium and ovary

被引:106
作者
Pike, MC [1 ]
Pearce, CL [1 ]
Wu, AH [1 ]
机构
[1] USC, Norris Canc Ctr, Los Angeles, CA 90089 USA
关键词
prevention; breast cancer; endometrial cancer; ovarian cancer;
D O I
10.1038/sj.onc.1207899
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A central epidemiological feature of cancers of the breast, endometrium and ovary is the sharp slowing down in their rate of increase with age around the time of menopause. The incidence of these tumors by the age of 70 years would be between fourfold and eightfold increased if the rapid increase with age seen in young women continued into old age. These phenomena can be explained by the different effects of ovarian hormones on cell division rates in the relevant tissues. Models of these effects provide a plausible explanation of most of the known epidemiology of each of the cancers, including the increase in breast cancer risk from menopausal estrogen-progestin therapy. Some recent epidemiological findings in endometrial and ovarian cancer suggest new avenues for possible chemoprevention of these cancers.
引用
收藏
页码:6379 / 6391
页数:13
相关论文
共 113 条
[91]  
Schairer C, 2000, JAMA-J AM MED ASSOC, V284, P693
[92]   Age at natural menopause and the risk of epithelial ovarian cancer [J].
Schildkraut, JM ;
Cooper, GS ;
Halabi, S ;
Calingaert, B ;
Hartge, P ;
Whittemore, AS .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (01) :85-90
[93]  
Schildkraut JM, 2002, JNCI-J NATL CANCER I, V94, P32
[94]   Height, weight, weight change, and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer [J].
Schouten, LJ ;
Goldbohm, RA ;
van den Brandt, PA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (05) :424-433
[95]   SERUM ESTROGEN-LEVELS IN POSTMENOPAUSAL WOMEN - COMPARISON OF AMERICAN WHITES AND JAPANESE IN JAPAN [J].
SHIMIZU, H ;
ROSS, RK ;
BERNSTEIN, L ;
PIKE, MC ;
HENDERSON, BE .
BRITISH JOURNAL OF CANCER, 1990, 62 (03) :451-453
[96]  
SIITERI PK, 1981, HORMONES BREAST CANC, P87
[97]  
SIMEONS ATW, 1954, LANCET, V2, P946
[98]   Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma [J].
Sit, ASY ;
Modugno, F ;
Weissfeld, JL ;
Berga, SL ;
Ness, RB .
GYNECOLOGIC ONCOLOGY, 2002, 86 (02) :118-123
[99]   CHANGES IN MAMMOGRAPHIC DENSITIES INDUCED BY A HORMONAL CONTRACEPTIVE DESIGNED TO REDUCE BREAST-CANCER RISK [J].
SPICER, DV ;
URSIN, G ;
PARISKY, YR ;
PEARCE, JG ;
SHOUPE, D ;
PIKE, A ;
PIKE, MC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (06) :431-436
[100]   PILOT TRIAL OF A GONADOTROPIN HORMONE AGONIST WITH REPLACEMENT HORMONES AS A PROTOTYPE CONTRACEPTIVE TO PREVENT BREAST-CANCER [J].
SPICER, DV ;
PIKE, MC ;
PIKE, A ;
RUDE, R ;
SHOUPE, D ;
RICHARDSON, J .
CONTRACEPTION, 1993, 47 (05) :427-444